Design of an ongoing phase I/II open-label, dose-escalation trial using the oral chelator deferasirox to treat iron overload in HFE-Related hereditary hemochromatosis (HH)
Abstract
Data di Pubblicazione:
2007
Citazione:
Design of an ongoing phase I/II open-label, dose-escalation trial using the oral chelator deferasirox to treat iron overload in HFE-Related hereditary hemochromatosis (HH) / Pietrangelo, Antonello; Brissot, P; Bonkovsky, H; Niederau, C; Rojkjaer, L; Weitzman, R; Bodner, J; Bailey, S; Phatak, Pd. - In: BLOOD. - ISSN 0006-4971. - 110:11(2007), pp. 788A-788A. ( 49th Annual Meeting of the American-Society-of-Hematology Atlanta, GA DEC 08-11, 2007).
Abstract:
no abstract available
Tipologia CRIS:
Abstract in Atti di Convegno
Elenco autori:
Pietrangelo, Antonello; Brissot, P; Bonkovsky, H; Niederau, C; Rojkjaer, L; Weitzman, R; Bodner, J; Bailey, S; Phatak, Pd
Link alla scheda completa:
Titolo del libro:
BLOOD
Pubblicato in: